Renato de Filippis: University Magna Graecia of Catanzaro, Italy
Mohammadreza Shalbafan: Iran University of Medical Sciences, Iran
Submission Status: Open | Submission Deadline: 1 May 2024
BMC Psychiatry welcomes submissions for the collection on “Human psychopharmacology: Efficacy and effectiveness of CNS drugs in psychiatric disorders.”
Modern clinical psychopharmacology can be dated to the introduction of lithium carbonate to treat mania in 1949. A year later, the introduction of chlorpromazine proved to be effective in the treatment of mania and psychotic disorders. Research in psychopharmacology continues on a path of evidence-based, methodological improvement, which endures today leading to significant progress in clinical practice. Innovation is essential for the identification of novel pharmacological therapies to meet the treatment needs of patients with psychiatric disorders. For this reason, we invite submissions covering various topics on the efficacy and effectiveness of central nervous system (CNS) drugs in psychiatric disorders.
This collection supports and amplifies research related to SDG 3: Good Health & Wellbeing.